Back to Agenda
Session 6: Block Chain
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management
Novo Nordisk, United Kingdom
Blockchain technology increases security and speeds up the exchange of information in a way that is cost-effective and more transparent. This technology has been increasingly used and considered in the healthcare sector as it can be applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, supply chain compliance, among many others. At this session, you will hear key stakeholders and users of Blockchain in Drug Development discussing challenges, risks and benefits.
Speaker(s)
Regulator View
Representative Invited
FDA
The Patient Advocate Perspective
Jeanne Barnett
CysticFibrosis.com, United States
Pathfinder for Patients and Caregivers, Teacher, CEO/Founder
Heather Flannery
Equideum Health, United States
Founder and Chief Executive Officer
Have an account?